These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17276894)

  • 1. Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis.
    Coopman K; Smith LD; Wright KL; Ward SG
    Int Immunopharmacol; 2007 Mar; 7(3):360-71. PubMed ID: 17276894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.
    Ghosh S; Preet A; Groopman JE; Ganju RK
    Mol Immunol; 2006 Jul; 43(14):2169-79. PubMed ID: 16503355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils.
    Oka S; Ikeda S; Kishimoto S; Gokoh M; Yanagimoto S; Waku K; Sugiura T
    J Leukoc Biol; 2004 Nov; 76(5):1002-9. PubMed ID: 15316028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis for neuroimmune receptor signaling.
    Rogers TJ
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):722-4. PubMed ID: 22935971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures.
    Kreutz S; Koch M; Ghadban C; Korf HW; Dehghani F
    Exp Neurol; 2007 Jan; 203(1):246-57. PubMed ID: 17010339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
    Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
    Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes.
    Sotsios Y; Whittaker GC; Westwick J; Ward SG
    J Immunol; 1999 Dec; 163(11):5954-63. PubMed ID: 10570282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes.
    Lu Y; Akinwumi BC; Shao Z; Anderson HD
    J Cardiovasc Pharmacol; 2014 Nov; 64(5):420-30. PubMed ID: 24979612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
    Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
    Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the cannabinoid system for pain relief?
    Chiou LC; Hu SS; Ho YC
    Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
    Baldassano S; Serio R; Mule' F
    Eur J Pharmacol; 2008 Mar; 582(1-3):132-8. PubMed ID: 18234188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ephrin stimulation modulates T cell chemotaxis.
    Sharfe N; Freywald A; Toro A; Dadi H; Roifman C
    Eur J Immunol; 2002 Dec; 32(12):3745-55. PubMed ID: 12516569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional CB2 type cannabinoid receptors at CNS synapses.
    Morgan NH; Stanford IM; Woodhall GL
    Neuropharmacology; 2009 Sep; 57(4):356-68. PubMed ID: 19616018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants.
    Kishimoto S; Oka S; Gokoh M; Sugiura T
    Int Arch Allergy Immunol; 2006; 140 Suppl 1():3-7. PubMed ID: 16772720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of platelet activation induced by endocannabinoids in blood and plasma.
    Brantl SA; Khandoga AL; Siess W
    Platelets; 2014; 25(3):151-61. PubMed ID: 23789792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J; Charron S; Bouchard JF; Beaulieu P
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids and the human uterus during pregnancy.
    Dennedy MC; Friel AM; Houlihan DD; Broderick VM; Smith T; Morrison JJ
    Am J Obstet Gynecol; 2004 Jan; 190(1):2-9; discussion 3A. PubMed ID: 14749627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.
    Kaplan BL; Ouyang Y; Herring A; Yea SS; Razdan R; Kaminski NE
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):107-15. PubMed ID: 15893538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.